Clinical Trials

Lung Neoplasms

NCT07609121 2026-05-27

Hypofractionated Chemoradiotherapy With Tislelizumab and Surufatinib for Unresectable Stage III NSCLC

160 enrolled

Carcinoma, Non-Small-Cell Lung

NCT00846742 2026-05-26

Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Favorable-Risk Hodgkin Lymphoma

Phase NA Active not recruiting

88 enrolled 21 charts

Lymphoid

Hodgkin Disease

NCT02177292 2026-05-26

SIB

80 enrolled

Phase 1/2 Active not recruiting

Prostatic Neoplasms

NCT04588545 2026-05-26

Radiation Therapy Followed by Intrathecal Trastuzumab/Pertuzumab in HER2+ Breast Leptomeningeal Disease

33 enrolled

Phase EARLY_PHASE1 Active not recruiting

Meningeal Neoplasms, Meningeal Carcinomatosis

NCT04648904 2026-05-26

Study of a Shortened Radiation Therapy Schedule in People With Breast Cancer

71 enrolled

Breast

Invasive Breast Cancer

NCT07607431 2026-05-26

AWARE

Active not recruiting

214 enrolled

Lymphedema, Prostatic Neoplasms

NCT00077285 2026-05-22

Irinotecan and Carboplatin as Upfront Window Therapy in Treating Patients With Newly Diagnosed Intermediate-Risk or High-Risk Rhabdomyosarcoma

65 enrolled

Sarcoma

Malignant mesenchymal tumor, Rhabdomyosarcoma, Sarcoma

NCT02186847 2026-05-22

Chemotherapy and Radiation Therapy With or Without Metformin Hydrochloride in Treating Patients With Stage III Non-small Cell Lung Cancer

Phase 2 Completed

170 enrolled 19 charts

Phase 1 Active not recruiting

Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar, Carcinoma, Non-Small-Cell Lung

NCT04484909 2026-05-22

NBTXR3 Activated by Radiation Therapy for the Treatment of Locally Advanced or Borderline-Resectable Pancreatic Cancer

24 enrolled

Pancreatic Neoplasms

NCT04503694 2026-05-22

REGINA

72 enrolled

Rectal Neoplasms

NCT05800574 2026-05-22

Lymphoscintigraphy Directed Elective Neck Radiation for p16+ Favorable Risk Oropharynx Cancer

22 enrolled

Oropharyngeal Neoplasms

NCT06813664 2026-05-22

CURB-TKI

60 enrolled

Phase 1 Not yet recruiting

Carcinoma, Non-Small-Cell Lung

NCT07478848 2026-05-22

Radiation, Oral Vancomycin, and CAR-T for B-Cell Lymphomas

14 enrolled

Lymphoid

Lymphoma, Non-Hodgkin, Lymphoma, Large B-Cell, Diffuse

NCT03274687 2026-05-20

Hypofractionated Radiation Therapy or Conventional Radiation Therapy After Surgery in Treating Patients With Prostate Cancer

Phase 3 Completed

296 enrolled 29 charts

Phase 3 Active not recruiting

Prostate Adenocarcinoma

NCT03987386 2026-05-20

Conventional or Hypofractionated Radiation Therapy in Treating Patients With Prostate Cancer

186 enrolled

Prostatic Neoplasms

NCT04555577 2026-05-20

Peposertib and Radiation Therapy, Followed by Temozolomide for the Treatment of Patients With Newly Diagnosed MGMT Unmethylated Glioblastoma or Gliosarcoma

29 enrolled

CNSSarcoma

Glioblastoma, Gliosarcoma

NCT04879940 2026-05-20

Phase II Study to Evaluate the Safety and Efficacy of Prostatic Artery Embolization

17 enrolled

Prostatic Hyperplasia, Prostatic Neoplasms

NCT07162506 2026-05-19

DCRT vs. Surgery in Resectable ESCC Patient Achiving cCR/PR After nCI

120 enrolled

Phase 3 Active not recruiting

Esophageal Neoplasms

NCT07477626 2026-05-19

RADVAN

372 enrolled

Prostatic Neoplasms

NCT07594925 2026-05-19

Short-Course Radiotherapy Followed by Immunotherapy Combined With Chemotherapy for Microsatellite Stable Locally Advanced Rectal Cancer: A Prospective, Randomized, Controlled Phase II Clinical Trial

130 enrolled

Rectal Neoplasms

NCT07595770 2026-05-19

ANCRE

37 enrolled

Esophageal Squamous Cell Carcinoma

NCT03279237 2026-05-18

A Pilot Study of FOLFIRINOX in Combination With Neoadjuvant Radiation for Gastric and GE Junction Cancers

Phase 1 Completed

25 enrolled 9 charts

GastroEsophageal Cancer

NCT07497607 2026-05-18

REDUCE-30

31 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT02444741 2026-05-15

Pembrolizumab and Stereotactic Body Radiation Therapy or Non-Stereotactic Wide-Field Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer

Phase 1/2 Completed

124 enrolled 15 charts

Carcinoma, Non-Small-Cell Lung

NCT04947254 2026-05-15

Androgen Ablation Therapy With or Without Niraparib After Radiation Therapy for the Treatment of High-Risk Localized or Locally Advanced Prostate Cancer

200 enrolled

Prostatic Neoplasms

NCT05574101 2026-05-15

A Study of Radiation Therapy and Cemiplimab for People With Skin Cancer

34 enrolled

Dermatologic

Carcinoma, Squamous Cell, Skin Neoplasms

NCT06702033 2026-05-15

MINT-2

142 enrolled

Phase 1 Active not recruiting

Oropharyngeal Neoplasms

NCT04477200 2026-05-14

Mycophenolate Mofetil Combined With Radiation Therapy in Glioblastoma

68 enrolled 20 charts

CNSSarcoma

Glioblastoma, Gliosarcoma

NCT04614909 2026-05-14

Study of Pamiparib in Newly Diagnosed and rGBM

Phase EARLY_PHASE1 Completed

50 enrolled

Glioblastoma

NCT04789486 2026-05-14

Nano-SMART: Nanoparticles With MR Guided SBRT in Centrally Located Lung Tumors and Pancreatic Cancer

Phase 1/2 Recruiting

100 enrolled

Carcinoma, Non-Small-Cell Lung

NCT06586255 2026-05-14

Adjuvant Concurrent Immunotherapy and Radiotherapy for the Treatment of Bladder Cancer

10 enrolled

Urinary Bladder Neoplasms

NCT06934889 2026-05-14

Study of ABBV-637 or ABBV-155 With ERAS-801 for People With Glioblastoma

60 enrolled

CNSSarcoma

Glioblastoma, Gliosarcoma

NCT07053085 2026-05-14

A Study of Surgery and Radiotherapy in People With Breast Cancer

178 enrolled

Breast

Breast Neoplasms

NCT07517705 2026-05-13

MRD-Adapted Low-Dose Radiation Therapy During Frontline Chemoimmunotherapy for Diffuse Large B-Cell Lymphoma

50 enrolled

Lymphoid

Lymphoma, Large B-Cell, Diffuse, Neoplasm, Residual

NCT01972919 2026-05-12

MR Guided Phase II Radiotherapy Dose Escalation in Unresectable Non-Metastatic Pancreatic Cancer

23 enrolled 8 charts

Phase 1 Active not recruiting

Pancreatic Neoplasms

NCT05615142 2026-05-11

Safety and Tolerability of Low Dose Radiotherapy Concurrent SBRT and PD-1 Inhibitors in Advanced NSCLC.

9 enrolled

NSCLC

NCT05941741 2026-05-11

IC Plus Low-dose Radiation Plus Cadonilimab in LANPC

Phase 3 Recruiting

380 enrolled

Nasopharyngeal Carcinoma

NCT06323239 2026-05-11

SBRT and LDRT Combined With PD-1 Antibody and Chemotherapy in r/m Nasopharyngeal Carcinoma

148 enrolled

Nasopharyngeal Carcinoma

NCT06758830 2026-05-11

Total Neoadjuvant Therapy and Organ Preservation Versus Surgery for Rectal Cancer.

Phase 2/3 Recruiting

400 enrolled

Low Anterior Resection Syndrome, Fatigue, Postoperative Complications, Radiation Injuries, Rectal Neoplasms

NCT06992427 2026-05-11

HOPE

Phase 3 Recruiting

228 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT07188532 2026-05-11

BEAR

Phase NA Recruiting

141 enrolled

Sarcoma

Sarcoma, Ewing

NCT07578519 2026-05-11

Radiation Treatment of the Prostate That is Specially Adjusted for Each Person

50 enrolled

Prostatic Neoplasms

NCT05092412 2026-05-08

Low-dose Radiotherapy Combined With Durvalumab, Chemotherapy(EP) in the Treatment of ES-SCLC

30 enrolled

Phase NA Active not recruiting

Lung Neoplasms, Small Cell Lung Carcinoma

NCT05464667 2026-05-08

Preoperative Irradiation for Stage I Breast Cancer

15 enrolled

Breast

Breast Neoplasms

NCT06019468 2026-05-08

Neoadjuvant Treatment For Locally Advanced Thymic Cancer

25 enrolled

Thymoma

NCT06431685 2026-05-08

Safety and Efficacy of Whole Brain LDRT+ICI+Intrathecal Chemotherapy in Refractory Meningeal Metastasis of Lung Cancer

10 enrolled

Phase 3 Active not recruiting

Meningeal Carcinomatosis

NCT03186898 2026-05-07

Radiation Therapy With Protons or Photons in Treating Patients With Liver Cancer

186 enrolled

Carcinoma, Hepatocellular

NCT04105374 2026-05-07

Testing the Addition of an Anti-cancer Viral Gene Therapy, Toca 511/Toca FC, to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed Glioblastoma

Phase 2/3 Withdrawn